Fortis loses Supreme Court challenge against forensic audit in ₹3,500 crore Daiichi case
A governance development with market-wide reach.
25 Sept 2026 · LiveMint Companies
The case is linked to a ₹3,500 crore arbitral award passed in favour of Daiichi Sankyo in 2016. The dispute goes back to the sale of Ranbaxy Laboratories by the Singh brothers to Daiichi Sankyo in 2008.
The analysis
This is a Governance / audit event. Governance events compress the valuation multiple faster than they impair earnings, and the recovery requires a visible remedy rather than time.
Related coverage
Penny stock under ₹10 hits 5% upper circuit after this fundraising update | Do you own?
Rahul Gandhi, Congress MPs Released From Detention After High-Stakes Protest Outside EC Office | Watch
Who is Sanjeev Moghe? Axis Bank Group Head resigns after 8 years; read his resignation letter: ‘I leave with a...’
Vedanta dividend countdown: Anil Agarwal-led company to consider first FY27 payout on October 8